Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.8877USD
−21.27 MUSD
26.59 M
About Coeptis Therapeutics Holdings, Inc.
Sector
Industry
CEO
David Mehalick
Website
Headquarters
Wexford
Employees (FY)
7
Founded
2017
FIGI
BBG00XTTT1C5
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of COEP is 0.3220 USD — it has decreased by 1.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Coeptis Therapeutics Holdings, Inc. stocks are traded under the ticker COEP.
Coeptis Therapeutics Holdings, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
COEP stock is 4.61% volatile and has beta coefficient of −1.18. Check out the list of the most volatile stocks — is Coeptis Therapeutics Holdings, Inc. there?
COEP earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.20 USD resulting in a 30.00% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Coeptis Therapeutics Holdings, Inc. earnings.
Yes, you can track Coeptis Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
COEP stock has fallen by 12.95% compared to the previous week, the month change is a 6.31% rise, over the last year Coeptis Therapeutics Holdings, Inc. has showed a 75.42% decrease.
COEP net income for the last quarter is −3.76 M USD, while the quarter before that showed −6.35 M USD of net income which accounts for 40.86% change. Track more Coeptis Therapeutics Holdings, Inc. financial stats to get the full picture.
Today Coeptis Therapeutics Holdings, Inc. has the market capitalization of 11.62 M, it has decreased by 4.05% over the last week.
No, COEP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, COEP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coeptis Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is Coeptis Therapeutics Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coeptis Therapeutics Holdings, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coeptis Therapeutics Holdings, Inc. stock shows the sell signal. See more of Coeptis Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.